U.S. consumers pay higher prices for weight loss drugs than any other country in the world, according to a 2023 KFF study.

Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...

Wegovy, which is the weight loss version of the drug Ozempic, was the first weight loss drug to receive FDA approval since ...

Tirzepatide is one of a group of weight-loss drugs known as GLP-1 receptor agonists ... Semaglutide, known by the brand names ...

Recent studies have found that Ozempic could lead to more muscle mass loss than traditional weight loss methods.

Ozempic, a drug initially used to treat type 2 diabetes, is gaining attention for its weight loss benefits and potential to reduce Alzheimer's risk. However, it comes with side effects like nausea, ...

No matter how much she ate, she never felt satisfied. But after starting a non-FDA approved GLP-1 agonist—an injectable drug ...

Novo Nordisk, the maker of Ozempic, reported that compounded versions of semaglutide ... for improving blood sugar control in ...

Researchers are weighing the effects of popular weight-loss medications like Ozempic on muscle mass. New work is "calling ...

Credit: Alones via Shutterstock. The seemingly inexorable rise in global obesity is being reflected in the sales of diabetes ...